IRON4U   Report issue

For profit Phase 3
Founded: Holte Denmark (2012)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2018
NCT03817957
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

IRON4U

Active Ingredients

Drugs in Phase 3 Trials (2)

ferric carboxymaltose (Injectafer) (2 trials)

ferrous sulfate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Deficiency Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2